Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy.
about
Remyelination Is Correlated with Regulatory T Cell Induction Following Human Embryoid Body-Derived Neural Precursor Cell Transplantation in a Viral Model of Multiple SclerosisDual-specific phosphatase-6 (Dusp6) and ERK mediate AMPA receptor-induced oligodendrocyte deathDealing with Danger in the CNS: The Response of the Immune System to Injury.Differential roles of microglia and monocytes in the inflamed central nervous systemImpaired autoimmune T helper 17 cell responses following DNA vaccination against rat experimental autoimmune encephalomyelitis.SLAT/Def6 plays a critical role in the development of Th17 cell-mediated experimental autoimmune encephalomyelitis.Analysis of the cellular mechanism underlying inhibition of EAE after treatment with anti-NKG2A F(ab')29-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes.Pien Tze Huang Gan Bao ameliorates carbon tetrachloride-induced hepatic injury, oxidative stress and inflammation in rats.Molecular mechanisms of T-cell receptor and costimulatory molecule ligation/blockade in autoimmune disease therapy.Therapeutic blockade of T-cell antigen receptor signal transduction and costimulation in autoimmune diseaseProtective effect of recombinant human IL-1Ra on CCl4-induced acute liver injury in mice.γδ T cell subsets play opposing roles in regulating experimental autoimmune encephalomyelitis.MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunityT-bet-dependent expression of osteopontin contributes to T cell polarization.A randomized controlled double-masked trial of albuterol add-on therapy in patients with multiple sclerosis.Peroxisome proliferator activated receptor-γ and traumatic brain injury.Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis.Genetic associations in type I interferon related pathways with autoimmunityNew approaches in the management of multiple sclerosis.IL-7Rα confers susceptibility to experimental autoimmune encephalomyelitis.Autophagy, inflammation and neurodegenerative disease.Multiple elements of the allergic arm of the immune response modulate autoimmune demyelination.Male microchimerism in peripheral blood leukocytes from women with multiple sclerosis.Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease.Disease-modifying therapies in multiple sclerosis: an update on recent and ongoing trials and future strategies.Gene therapy in autoimmune, demyelinating disease of the central nervous system.Combination treatment of mice with CRx-153 (nortriptyline and desloratadine) decreases the severity of experimental autoimmune encephalomyelitis.Remyelinating and neuroprotective treatments in multiple sclerosis.Regulation of the severity of neuroinflammation and demyelination by TLR-ASK1-p38 pathway.Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.Interleukin-7 is required for CD4(+) T cell activation and autoimmune neuroinflammation.Antigen-specific therapies in multiple sclerosis: going beyond proteins and peptides.Cytosolic phospholipase A2 alpha-deficient mice are resistant to experimental autoimmune encephalomyelitis.Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells.Magnetic resonance imaging reveals therapeutic effects of interferon-beta on cytokine-induced reactivation of rat model of multiple sclerosisTargeting the B7 family of co-stimulatory molecules: successes and challenges.Stat4 isoforms differentially regulate inflammation and demyelination in experimental allergic encephalomyelitis.Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists.Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells.
P2860
Q27339236-BF035D5F-AD44-4DB5-96D1-E570BFDE942EQ28566860-82D06CA1-9563-494A-8A62-C752802CB650Q30279070-9592DC3C-0C6E-4A42-8F1E-B6CBBAA0686BQ30585165-8B2D5EFF-6362-4D1C-BD81-6F38F446F2EFQ30853672-96F2CDE6-79A0-4A67-85AF-CAFC1DCB9387Q33652849-DEA881B0-8A7C-4E9D-9FE4-1DAFA102BA7DQ33664396-468266D0-119B-49B7-B25C-408BC6E26B1EQ33674869-794DC0E8-6123-428B-A94B-38F80B215D67Q33723975-A0EBAB18-51EB-4529-945E-158D82A7175FQ33753720-24FE970A-E525-404C-A891-4B04756697E1Q33785953-2D3C3B6B-B65E-4BE4-A364-F8DA244BC0B2Q33903615-5F828EA8-83F0-4CFD-A7B3-698824A9AED2Q33964713-E60352D6-D068-453F-ABD0-AB5918561D53Q34096499-943C3D3C-239A-4311-9A95-4066AF79DB3CQ34144801-296A267F-863D-4FC6-882F-A0398DECDA7DQ34194343-C8132E3B-4878-44FF-9A2C-E4C77DCACE1DQ34271250-67CF3912-6C14-4F1C-B4B7-937E45DF210DQ34311395-640E336C-47D5-440C-8D80-8FB7AD9C8A04Q34350182-FC1B8308-D7B7-40E8-AA03-013189E0AB3BQ34389528-FF6781DA-E2AE-4247-BCA8-42418D8630F9Q34507783-FCA66A86-D26C-4284-A760-7C3B1DAFBE04Q34686890-38D2E1A2-E734-4170-87C2-4C424172F447Q34762330-96BEE2F7-4F27-46FA-B700-DB2830502F5FQ34890939-83DB2512-E463-488B-B437-E57E2548C344Q34968165-3B06DBFF-ECE9-43DA-A6C4-4CAC8ED44164Q35094706-E7AC7C8C-2295-4BFA-9FE7-97CC63FAC730Q35122159-C71A9222-C312-4585-988A-80672D540201Q35166937-B90D5D70-0935-430D-87D2-753722CF03C4Q35753458-EF51752E-FAE8-4FAE-9660-514BE33F36B7Q36039356-12BE5224-6088-4B41-A982-1A2EBFA77426Q36228251-56C6F561-FAF5-4830-9115-D07A9D977A24Q36315737-8C0E88CD-738A-45C2-8333-A084FABB3E15Q36327377-5ABAAE27-C155-4595-9029-620C772B8697Q36403041-942FB6BA-F482-45A6-AA09-F7606B1A5115Q36482311-4EA9F15B-58CA-4643-9B61-D3E7BD90353AQ36839991-3406A3E5-D9BE-49F5-BF89-8FF6543567D6Q36841260-BA2B6C18-65DE-45C5-9AA9-35D5E44A4F4CQ36968143-3D2D0470-AF1A-4B33-BE7B-06492405D1AFQ36992256-EEF59CE8-FC01-4039-A7CF-139CD9BE143AQ37050067-E82541BE-8716-4FC1-AB9C-8FAD7ADC2451
P2860
Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Multiple sclerosis: deeper und ...... veals new targets for therapy.
@ast
Multiple sclerosis: deeper und ...... veals new targets for therapy.
@en
Multiple sclerosis: deeper und ...... veals new targets for therapy.
@nl
type
label
Multiple sclerosis: deeper und ...... veals new targets for therapy.
@ast
Multiple sclerosis: deeper und ...... veals new targets for therapy.
@en
Multiple sclerosis: deeper und ...... veals new targets for therapy.
@nl
prefLabel
Multiple sclerosis: deeper und ...... veals new targets for therapy.
@ast
Multiple sclerosis: deeper und ...... veals new targets for therapy.
@en
Multiple sclerosis: deeper und ...... veals new targets for therapy.
@nl
P2093
P1476
Multiple sclerosis: deeper und ...... eveals new targets for therapy
@en
P2093
Claude Bernard
Jorge R Oksenberg
Lawrence Steinman
Paul Conlon
P304
P356
10.1146/ANNUREV.NEURO.25.112701.142913
P50
P577
2002-03-27T00:00:00Z